PDCD1 and hepatocellular carcinoma: Notably, although tumour‐bearing mice from CD74KO HCC cells achieved complete tumour regression after the combined treatment of anti‐PD1 antibody and LSD1 inhibitor, tumour recurrence occurred after discontinuation of the combined therapy.